Merck KGaA's Allergopharma opens production facility

By Gareth Macdonald contact

- Last updated on GMT

iStock/goa_novi
iStock/goa_novi

Related tags: Asthma, Immune system, Merck kgaa

Merck KGaA has opened a €42m production facility in Reinbek near Hamburg, Germany.

The 6,000sqm facility​ will be operated by Merck’s subsidiary Allergopharma and will focus on the production of treatments for allergy, including allergic asthma and hay fever.

Merck has been constructing the facility since 2013. At the time​ the firm said the facility would support expansion into new markets including China.

This was reiterated by COO Simon Sturge who said on Thursday that the facility is part of a "global expansion, and will support our growing business in the allergy market place.”

Related news

Related products

show more

Strategies to Achieve Successful Approval & Launch

Strategies to Achieve Successful Approval & Launch

Catalent Pharma Solutions | 03-Sep-2020 | Data Sheet

There are several key considerations to how companies should approach commercial-scale manufacturing that may aid the success of their biologic’s launch...

Single-Pass Tangential Flow Filtration

Single-Pass Tangential Flow Filtration

BioContinuum™ Platform - MilliporeSigma | 01-Aug-2020 | Application Note

Tangential flow filtration (TFF) is widely used in the biopharmaceutical industry for downstream processing applications. Typical TFF steps concentrate...

Follow us

Products

View more

Webinars